These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 27540597)

  • 1. Trends and challenges in immuno-oncology trials.
    Kiernan B
    Drugs Today (Barc); 2016 Jul; 52(7):387-93. PubMed ID: 27540597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotherapeutics for Immuno-Oncology: A Crossroad for New Paradigms.
    Song W; Das M; Chen X
    Trends Cancer; 2020 Apr; 6(4):288-298. PubMed ID: 32209444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New immunological concepts in oncology].
    Versicherungsmedizin; 2013 Sep; 65(3):156-7. PubMed ID: 24137899
    [No Abstract]   [Full Text] [Related]  

  • 4. The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017).
    Golan T; Milella M; Ackerstein A; Berger R
    J Exp Clin Cancer Res; 2017 Dec; 36(1):192. PubMed ID: 29282151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: The State-of-Art in Immuno-Oncology, What to Do With Glioblastoma?
    Cui X; Wang Q; Kang C
    Front Immunol; 2021; 12():788733. PubMed ID: 34777399
    [No Abstract]   [Full Text] [Related]  

  • 6. Personalized Oncology Meets Immunology: The Path toward Precision Immunotherapy.
    Mandal R; Chan TA
    Cancer Discov; 2016 Jul; 6(7):703-13. PubMed ID: 27107038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immuno-oncology and precision medicine: The clinician point of view].
    Borg C
    Ann Pathol; 2017 Feb; 37(1):5-6. PubMed ID: 28159403
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer research: Promise of protection.
    Chi KR
    Nature; 2011 Mar; 471(7339):537-8. PubMed ID: 21438188
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer immunotherapy without frontiers: 2nd Annual Immuno-Oncology Meeting of the Centro de Investigación de Cancer en Sonora (CICS), Ciudad Obregón, Sonora México, Dec 2-4, 2016.
    Gallardo-Rincón D; Marquez JP; Celis E
    Cancer Immunol Immunother; 2017 Sep; 66(9):1243-1247. PubMed ID: 28484800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immuno-oncology drug development forges on despite COVID-19.
    Upadhaya S; Hubbard-Lucey VM; Yu JX
    Nat Rev Drug Discov; 2020 Nov; 19(11):751-752. PubMed ID: 32948858
    [No Abstract]   [Full Text] [Related]  

  • 11. Immuno-oncology combinations: a review of clinical experience and future prospects.
    Antonia SJ; Larkin J; Ascierto PA
    Clin Cancer Res; 2014 Dec; 20(24):6258-68. PubMed ID: 25341541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Tumor immunology meets oncology" (TIMO) XI, May 22-23, 2015, Halle/Saale, Germany.
    Quandt D; Seliger B
    Cancer Immunol Immunother; 2016 May; 65(5):625-30. PubMed ID: 27060001
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future.
    Blair AB; Murphy A
    Curr Probl Cancer; 2018; 42(1):49-58. PubMed ID: 29501212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Precision Medicine in Oncology: Immuno-oncology.
    Buchbinder EI; Hodi FS
    Cancer J; 2023 Jan-Feb 01; 29(1):15-19. PubMed ID: 36693153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immuno-Oncology in China.
    Lu S; Chabner BA
    Oncologist; 2019 Feb; 24(Suppl 1):S1-S2. PubMed ID: 30819825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunotherapy in lung cancer: New concepts].
    Goubet AG; Livartowski A; Romano E
    Rev Mal Respir; 2018 Jun; 35(6):642-651. PubMed ID: 29941206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immuno-oncology and Its Opportunities for Interventional Radiologists: Immune Checkpoint Inhibition and Potential Synergies with Interventional Oncology Procedures.
    Hickey RM; Kulik LM; Nimeiri H; Kalyan A; Kircher S; Desai K; Riaz A; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2017 Nov; 28(11):1487-1494. PubMed ID: 28912090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer vaccines.
    Chekhun VF
    Exp Oncol; 2008 Jun; 30(2):90. PubMed ID: 18680872
    [No Abstract]   [Full Text] [Related]  

  • 19. From immune checkpoints to vaccines: The past, present and future of cancer immunotherapy.
    Osipov A; Murphy A; Zheng L
    Adv Cancer Res; 2019; 143():63-144. PubMed ID: 31202363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Nanomedicine: Lessons for Immuno-Oncology.
    Sengupta S
    Trends Cancer; 2017 Aug; 3(8):551-560. PubMed ID: 28780932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.